Finally, in terms of tumor access, IL-6 has been described as the key glioblastoma-derived factor that promotes anti-inflammatory and wound-healing type responses, inducing strategic tissue remodeling to prevent immunologic access to the tumor by T cells [43]. Here, IL6 is linked to glioblastoma.